JavaScript is NOT enabled !

Please enable JavaScript.

Article

FT
PubMed

This record comes from PubMed

Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant

Yamasoba, Daichi
Author Yamasoba, Daichi Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; Faculty of Medicine, Kobe University, Kobe, Japan
Uriu, Keiya
Author Uriu, Keiya Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; The Institute of Medical Science, and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Plianchaisuk, Arnon
Author Plianchaisuk, Arnon Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan
Kosugi, Yusuke
Author Kosugi, Yusuke Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; The Institute of Medical Science, and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Pan, Lin
Author Pan, Lin Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan
Zahradnik, Jiri
Author Zahradnik, Jiri First Medical Faculty at Biocev, Charles University, Vestec-Prague, Czechia
Genotype to Phenotype Japan (G2P-Japan) Consortium
Author Genotype to Phenotype Japan (G2P-Japan) Consortium
Ito, Jumpei
Author Ito, Jumpei Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; International Research Center for Infectious Diseases, The University of Tokyo, Tokyo, Japan
Sato, Kei
Author Sato, Kei Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; International Research Center for Infectious Diseases, The University of Tokyo, Tokyo, Japan; International Vaccine Design Center, The University of Tokyo, Tokyo, Japan; The Institute of Medical Science, and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan; CREST, Japan Science and Technology Agency, Kawaguchi, Japan. Electronic address: keisato@g.ecc.u-tokyo.ac.jp

The Lancet. Infectious diseases. 2023 Jun ; 23 (6) : 655-656. [epub] 20230503

Lancet Infect Dis
ISSN 1474-4457 | 1473-3099
Source

Language English Country United States Media print-electronic

Document type Letter

Persistent link https://www.medvik.cz/link/pmid37148902

Online Full text

PubMed 37148902
PubMed Central PMC10156138
DOI 10.1016/s1473-3099(23)00278-5
PII: S1473-3099(23)00278-5
Knihovny.cz E-resources

MeSH
COVID-19 * MeSH
Humans MeSH
SARS-CoV-2 * genetics MeSH
Check Tag
Humans MeSH
Publication type
Letter MeSH

1st Medical Faculty at Biocev Charles University Vestec Prague Czechia

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan; Faculty of Medicine Kobe University Kobe Japan

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan; Graduate School of Frontier Sciences The University of Tokyo Kashiwa Japan

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan; International Research Center for Infectious Diseases The University of Tokyo Tokyo Japan

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan; International Research Center for Infectious Diseases The University of Tokyo Tokyo Japan; International Vaccine Design Center The University of Tokyo Tokyo Japan; The Institute of Medical Science and Graduate School of Medicine The University of Tokyo Tokyo Japan; Graduate School of Frontier Sciences The University of Tokyo Kashiwa Japan; Collaboration Unit for Infection Joint Research Center for Human Retrovirus infection Kumamoto University Kumamoto Japan; CREST Japan Science and Technology Agency Kawaguchi Japan

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan; The Institute of Medical Science and Graduate School of Medicine The University of Tokyo Tokyo Japan

See more in PubMed

WHO Tracking SARS-CoV-2 variants. March 30, 2023. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants

Zahradnik J, Marciano S, Shemesh M, et al. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nat Microbiol. 2021;6:1188–1198. PubMed

Tamura T, Ito J, Uriu K, et al. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two omicron subvariants. bioRxiv. 2022 doi: 10.1101/2022.12.27.521986. published online Dec 27. (preprint). PubMed DOI PMC

Smith DJ, Lapedes AS, de Jong JC, et al. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305:371–376. PubMed

Borrow
RIS

Find record

In BMC

Citation metrics